Brossi; Arnold

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brossi; Arnold.The latest application filed is for "thalidomide analogs".

Company Profile

0.16.12

Brossi; Arnold - Bethesda MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Thalidomide Analogs App 20140309436 - Greig; Nigel H. ; et al.	2014-10-16
Thalidomide analogs Grant 8,853,253 - Greig , et al. October 7, 2	2014-10-07
Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof Grant 8,691,864 - Greig , et al. April 8, 2	2014-04-08
Thalidomide analogs Grant 8,546,430 - Greig , et al. October 1, 2	2013-10-01
Thalidomide Analogs App 20130035363 - Greig; Nigel H. ; et al.	2013-02-07
Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof App 20120295946 - Greig; Nigel H. ; et al.	2012-11-22
Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof Grant 8,258,172 - Greig , et al. September 4, 2	2012-09-04
Tylophorine analogs as antitumor agents Grant 8,188,089 - Lee , et al. May 29, 2	2012-05-29
Thalidomide Analogs App 20110245210 - Greig; Nigel H. ; et al.	2011-10-06
Thalidomide analogs Grant 7,973,057 - Greig , et al. July 5, 2	2011-07-05
Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof App 20110021594 - Greig; Nigel H. ; et al.	2011-01-27
Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof Grant 7,786,162 - Greig , et al. August 31, 2	2010-08-31
Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof App 20090131501 - Greig; Nigel H. ; et al.	2009-05-21
Tylophorine Analogs as Antitumor Agents App 20080300254 - Lee; Kuo-Hsiung ; et al.	2008-12-04
Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof Grant 7,153,882 - Greig , et al. December 26, 2	2006-12-26
Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof App 20060270729 - Greig; Nigel H. ; et al.	2006-11-30
Thalidomide analogs App 20060211728 - Greig; Nigel H. ; et al.	2006-09-21
Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof App 20040138282 - Greig, Nigel H. ; et al.	2004-07-15
Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias Grant 6,683,105 - Greig , et al. January 27, 2	2004-01-27
Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias App 20020094999 - Greig, Nigel H. ; et al.	2002-07-18
Method for treating cognitive disorders with phenserine Grant 5,409,948 - Greig , et al. * April 25, 1	1995-04-25
Esters of 3-demethylthiocolchicine and n-acyl analogs Grant 5,175,342 - Brossi December 29, 1	1992-12-29
Substituted phenserines as specific inhibitors of acetylcholinesterase Grant 5,171,750 - Brossi , et al. December 15, 1	1992-12-15
Thermal fragmentation of methylbenzylurea disastereomers or secondary amines and preparation of optically active secondary amines Grant 5,039,801 - Brossi , et al. August 13, 1	1991-08-13
Carbamates related to (-)-physostigmine as cholinergic agents Grant 4,900,748 - Brossi , et al. February 13, 1	1990-02-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.